Theodore Pincus
Pincus, T.
Pincus, Theodore
Pincus, T. (Theodore), 1941-
Pincus, Theodore, 1941-
VIAF ID: 92175543 (Personal)
Permalink: http://viaf.org/viaf/92175543
Preferred Forms
-
100 1 _ ‡a Pincus, T.
-
-
100 1 0 ‡a Pincus, T. ‡q (Theodore), ‡d 1941-
-
-
100 1 _ ‡a Pincus, Theodore
-
-
-
100 1 _ ‡a Pincus, Theodore
-
-
100 0 _ ‡a Theodore Pincus
4xx's: Alternate Name Forms (11)
Works
Title | Sources |
---|---|
Combination disease-modifying antirheumatic drug therapy in rheumatoid arthritis |
![]() |
Continuous indices of core data set measures in rheumatoid arthritis clinical trials: lower responses to placebo than seen with categorical responses with the American College of Rheumatology 20% criteria |
![]() |
Criterion contamination of depression scales in patients with rheumatoid arthritis: the need for interpretation of patient questionnaires (as all clinical measures) in the context of all information about the patient |
![]() |
Differences in treat-to-target in patients with rheumatoid arthritis versus hypertension and diabetes--consequences for clinical care. |
![]() |
Discordance of Global Assessments by Patient and Physician Is Higher in Female than in Male Patients Regardless of the Physician's Sex: Data on Patients with Rheumatoid Arthritis, Axial Spondyloarthritis, and Psoriatic Arthritis from the DANBIO Regi |
![]() |
The disease activity score is not suitable as the sole criterion for initiation and evaluation of anti-tumor necrosis factor therapy in the clinic: discordance between assessment measures and limitations in questionnaire use for regulatory purposes |
![]() |
Documenting the value of care for rheumatoid arthritis, analogous to hypertension, diabetes, and hyperlipidemia: is control of individual patient self-report measures of global estimate and physical function more valuable than laboratory tests, radi |
![]() |
Effective initial and long-term prednisone in doses of less than 5 mg/day to treat rheumatoid arthritis--documentation using a patient self-report Multidimensional Health Assessment Questionnaire (MDHAQ). |
![]() |
Eosinophilia-Myalgia Syndrome: Review and Reappraisal |
![]() |
Erythrocyte sedimentation rate, C-reactive protein, or rheumatoid factor are normal at presentation in 35%-45% of patients with rheumatoid arthritis seen between 1980 and 2004: analyses from Finland and the United States |
![]() |
An evidence-based medical visit for patients with rheumatoid arthritis based on standard, quantitative scientific data from a patient MDHAQ and physician report. |
![]() |
Evidence-based practice and practice-based evidence |
![]() |
The HAQ compared with the MDHAQ: "keep it simple, stupid" (KISS), with feasibility and clinical value as primary criteria for patient questionnaires in usual clinical care |
![]() |
How to collect an MDHAQ to provide rheumatology vital signs (function, pain, global status, and RAPID3 scores) in the infrastructure of rheumatology care, including some misconceptions regarding the MDHAQ. |
![]() |
Implementation of Treat-to-Target in Rheumatoid Arthritis Through a Learning Collaborative: Results of a Randomized Controlled Trial |
![]() |
Importance of patient history and physical examination in rheumatoid arthritis compared to other chronic diseases: results of a physician survey |
![]() |
Inflammation-associated insulin resistance: differential effects in rheumatoid arthritis and systemic lupus erythematosus define potential mechanisms |
![]() |
Information technology in rheumatology |
![]() |
The legacies of Rudolf Virchow: cellular medicine in the 20th century and social medicine in the 21st century. |
![]() |
Limitations of randomized clinical trials in chronic diseases: explanations and recommendations. |
![]() |
Limited Value of the Multi-Biomarker Disease Activity Assay Compared to the Routine Assessment of Patient Index Data 3 |
![]() |
Making an impact on mortality in rheumatoid arthritis: targeting cardiovascular comorbidity |
![]() |
MDHAQ/RAPID3 can provide a roadmap or agenda for all rheumatology visits when the entire MDHAQ is completed at all patient visits and reviewed by the doctor before the encounter. |
![]() |
MDHAQ/RAPID3 scores: quantitative patient history data in a standardized "scientific" format for optimal assessment of patient status and quality of care in rheumatic diseases. |
![]() |
MDHAQ/RAPID3 to recognize improvement over 2 months in usual care of patients with osteoarthritis, systemic lupus erythematosus, spondyloarthropathy, and gout, as well as rheumatoid arthritis |
![]() |
Morning stiffness in patients with early rheumatoid arthritis is associated more strongly with functional disability than with joint swelling and erythrocyte sedimentation rate |
![]() |
Pain and other self-report scores in patients with osteoarthritis indicate generally similar disease burden to patients with rheumatoid arthritis |
![]() |
Pain, function, and RAPID scores: vital signs in chronic diseases, analogous to pulse and temperature in acute diseases and blood pressure and cholesterol in long-term health |
![]() |
The past versus the present, 1980-2004: reduction of mean initial low-dose, long-term glucocorticoid therapy in rheumatoid arthritis from 10.3 to 3.6 mg/day, concomitant with early methotrexate, with long-term effectiveness and safety of less than 5 |
![]() |
Patient preference in a crossover clinical trial of patients with osteoarthritis of the knee or hip: face validity of self-report questionnaire ratings. |
![]() |
Patient questionnaires and formal education level as prospective predictors of mortality over 10 years in 97% of 1416 patients with rheumatoid arthritis from 15 United States private practices. |
![]() |
Patient questionnaires for clinical research and improved standard patient care: is it better to have 80% of the information in 100% of patients or 100% of the information in 5% of patients? |
![]() |
Poor physical function, pain and limited exercise: risk factors for premature mortality in the range of smoking or hypertension, identified on a simple patient self-report questionnaire for usual care |
![]() |
Possible discontinuation of therapies in inflammatory rheumatic diseases - as with initiation of therapies, a shared decision between patient and rheumatologist. |
![]() |
Pragmatic assessment of exercise in routine care using an MDHAQ: associations with changes in RAPID3 and other clinical variables |
![]() |
Prediction of Remission in a French Early Arthritis Cohort by RAPID3 and other Core Data Set Measures, but Not by the Absence of Rheumatoid Factor, Anticitrullinated Protein Antibodies, or Radiographic Erosions |
![]() |
Preliminary evaluation of a visual analog function scale for use in rheumatoid arthritis |
![]() |
Quality control of a medical history: improving accuracy with patient participation, supported by a four-page version of the multidimensional health assessment questionnaire (MDHAQ). |
![]() |
Quantitative data for care of patients with systemic lupus erythematosus in usual clinical settings: a patient Multidimensional Health Assessment Questionnaire and physician estimate of noninflammatory symptoms |
![]() |
Quantitative measures of rheumatic diseases for clinical research versus standard clinical care: differences, advantages and limitations |
![]() |
Quantitative recording of physician clinical estimates, beyond a global estimate and formal joint count, in usual care: applying the scientific method, using a simple one-page worksheet |
![]() |
QUEST-RA: quantitative clinical assessment of patients with rheumatoid arthritis seen in standard rheumatology care in 15 countries |
![]() |
Radiographic measures to assess patients with rheumatoid arthritis: advantages and limitations |
![]() |
RAPID3, an index of only 3 patient self-report core data set measures, but not ESR, recognizes incomplete responses to methotrexate in usual care of patients with rheumatoid arthritis. |
![]() |
RAPID3-an index of physical function, pain, and global status as "vital signs" to improve care for people with chronic rheumatic diseases. |
![]() |
Remission and rheumatoid arthritis: data on patients receiving usual care in twenty-four countries |
![]() |
Responsiveness of a simple RAPID-3-like index compared to disease-specific BASDAI and ASDAS indices in patients with axial spondyloarthritis |
![]() |
Rheumatoid arthritis : pathogenesis, assessment, outcome, and treatment |
![]() ![]() ![]() |
RHEUMDOC: a one-page RHEUMatology DOCtor form with four physician global estimates for overall status, inflammation, damage, and symptoms based on neither inflammation nor damage. |
![]() |
RheuMetric A Physician Checklist to Record Patient Levels of Inflammation, Damage and Distress as Quantitative Data Rather than as Narrative Impressions |
![]() |
Routine Assessment of Patient Index Data (RAPID3) and Bath Ankylosing Spondylitis Disease Activity Index (BASDAI) Scores Yield Similar Information in 85 Korean Patients With Ankylosing Spondylitis Seen in Usual Clinical Care |
![]() |
Screening the genome for rheumatoid arthritis susceptibility genes: a replication study and combined analysis of 512 multicase families |
![]() |
A systematic comparison between rheumatoid arthritis and ankylosing spondylitis |
![]() |
Treatment of rheumatoid arthritis: a global perspective on the use of antirheumatic drugs |
![]() |
Update on imaging in rheumatic diseases |
![]() ![]() |
Update on methotrexate as the anchor drug for rheumatoid arthritis |
![]() |
Utility of the Framingham risk score to predict the presence of coronary atherosclerosis in patients with rheumatoid arthritis |
![]() |
Value of RAPID3 in patients with PsA: results from the TICOPA and LOPAS II databases |
![]() |
Visual analog scales in formats other than a 10 centimeter horizontal line to assess pain and other clinical data. |
![]() |
Work disability remains a major problem in rheumatoid arthritis in the 2000s: data from 32 countries in the QUEST-RA study |
![]() |